Understanding and exploiting hepcidin as an indicator of anemia due to chronic kidney disease
Hepcidin, produced by the liver, is the master regulator of iron balance. Serum hepcidin is increased by high iron stores, blocks intestinal iron absorption, and impairs storage iron release. Conversely, iron deficiency lowers hepcidin levels and enhances intestinal iron absorption and the release o...
Saved in:
Main Authors: | Derek S. Larson (Author), Daniel W. Coyne (Author) |
---|---|
Format: | Book |
Published: |
The Korean Society of Nephrology,
2013-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GDF-15 and hepcidin as a therapeutic target for anemia in chronic kidney disease
by: Naglaa Makram Farag, et al.
Published: (2023) -
Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD)
by: Sung Woo Lee, et al.
Published: (2017) -
Iron, anemia and hepcidin in malaria
by: Natasha eSpottiswoode, et al.
Published: (2014) -
The relationship between anemia, serum hepcidin levels, and chronic hepatitis C in chronic hemodialysis patients
by: Maher A Al-Amir, et al.
Published: (2017) -
Profile of Daprodustat in the Treatment of Renal Anemia Due to Chronic Kidney Disease
by: Ishii T, et al.
Published: (2021)